Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA (2012) Parkinson’s disease. Subcell Biochem 65:389–455. https://doi.org/10.1007/978-94-007-5416-4_16
Article CAS PubMed PubMed Central Google Scholar
Tysnes O-B, Storstein A (2017) Epidemiology of Parkinson’s disease. J Neural Transm (Vienna) 124:901–905. https://doi.org/10.1007/s00702-017-1686-y
Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson’s disease. J Neurochem 139(Suppl 1):318–324. https://doi.org/10.1111/jnc.13691
Article CAS PubMed Google Scholar
Sommer C, Geber C, Young P, Forst R, Birklein F, Schoser B (2018) Polyneuropathies. Dtsch Arztebl Int 115:83–90. https://doi.org/10.3238/arztebl.2018.083
Article PubMed PubMed Central Google Scholar
Kühn E, Averdunk P, Huckemann S, Müller K, Biesalski A-S, zum Hof Berge F, Motte J, Fisse AL, Schneider-Gold C, Gold R et al (2020) Correlates of polyneuropathy in Parkinson’s disease. Ann Clin Transl Neurol 7:1898–1907. https://doi.org/10.1002/acn3.51182
Article CAS PubMed PubMed Central Google Scholar
Mathukumalli NL, Kandadai MR, Shaik JA, Kanikannan MA, Borgohain R (2020) Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson’s Disease: Indian Cohort. Ann Indian Acad Neurol 23:48–53. https://doi.org/10.4103/aian.AIAN_478_18
Article PubMed PubMed Central Google Scholar
Toth C, Breithaupt K, Ge S, Duan Y, Terris JM, Thiessen A, Wiebe S, Zochodne DW, Suchowersky O (2010) Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Ann Neurol 68:28–36. https://doi.org/10.1002/ana.22021
Article CAS PubMed Google Scholar
Hernandez Fustes OJ, Hernandez Fustes OJ (2020) Sensory Neuropathy in Parkinson Disease: Electrodiagnostic Evaluation. Neurodiagn J 60:177–184. https://doi.org/10.1080/21646821.2020.1796414
de Araújo DF, de Melo Neto AP, Oliveira ÍSC, Brito BS, de Araújo IT, Barros IS, Lima JWO, Horta WG, Gondim FdAA (2016) Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism. BMC Neurol 20:16. https://doi.org/10.1186/s12883-016-0667-3
Zis P, Grünewald RA, Chaudhuri RK, Hadjivassiliou M (2017) Peripheral neuropathy in idiopathic Parkinson’s disease: a systematic review. J Neurol Sci 378:204–209. https://doi.org/10.1016/j.jns.2017.05.023
Beaulieu ML, Müller ML, Bohnen NI (2018) Peripheral neuropathy is associated with more frequent falls in Parkinson’s disease. Parkinsonism Relat Disord 54:46–50. https://doi.org/10.1016/j.parkreldis.2018.04.006
Article PubMed PubMed Central Google Scholar
Tai Y-C, Lin C-H (2019) An overview of pain in Parkinson’s disease. Clin Park Relat Disord 2:1–8. https://doi.org/10.1016/j.prdoa.2019.11.004
Article PubMed PubMed Central Google Scholar
Paul DA, Qureshi ARM, Rana AQ (2020) Peripheral neuropathy in Parkinson’s disease. Neurol Sci 41:2691–2701. https://doi.org/10.1007/s10072-020-04407-4
Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752
Article CAS PubMed PubMed Central Google Scholar
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601. https://doi.org/10.1002/mds.26424
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442. https://doi.org/10.1212/wnl.17.5.427
Article CAS PubMed Google Scholar
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170. https://doi.org/10.1002/mds.22340
Chaudhuri KR, Martinez-Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, MacPhee G et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923. https://doi.org/10.1002/mds.20844
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O’Brien PC, Grina LA, Palumbo PJ, Swanson CJ (1980) Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 8:590–596. https://doi.org/10.1002/ana.410080608
Article CAS PubMed Google Scholar
Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357. https://doi.org/10.1093/ageing/26.5.353
Article CAS PubMed Google Scholar
Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC (2013) How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale: comparison with the unified Parkinson’s disease rating scale. Mov Disord 28:668–670. https://doi.org/10.1002/mds.25383
Carmichael J, Fadavi H, Ishibashi F, Shore AC, Tavakoli M (2021) Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Front Endocrinol (Lausanne) 12:671257. https://doi.org/10.3389/fendo.2021.671257
Stöhr M, Pfister R, Reilich P (2022) Klinische Elektromyographie und Neurographie: Lehrbuch und Atlas, 7 erweiterte und überarbeiteteAuflage. Kohlhammer Verlag, Stuttgart (ISBN 978-3-17-035043-4)
Ceravolo R, Cossu G, Di Bandettini Poggio M, Santoro L, Barone P, Zibetti M, Frosini D, Nicoletti V, Manganelli F, Iodice R et al (2013) Neuropathy and levodopa in Parkinson’s disease: evidence from a multicenter study. Mov Disord 28:1391–1397. https://doi.org/10.1002/mds.25585
Article CAS PubMed Google Scholar
Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D (2008) Neuropathy as a potential complication of levodopa use in Parkinson’s disease. Mov Disord 23:1850–1859. https://doi.org/10.1002/mds.22137
England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, Cohen JA, Fisher MA, Howard JF, Kinsella LJ et al (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64:199–207. https://doi.org/10.1212/01.WNL.0000149522.32823.EA
Article CAS PubMed Google Scholar
Mücke M, Cuhls H, Radbruch L, Baron R, Maier C, Tölle T, Treede R-D, Rolke R (2021) Quantitative sensorische Testung (QST). Schmerz 35:153–160. https://doi.org/10.1007/s00482-015-0093-2
Gasparotti R, Padua L, Briani C, Lauria G (2017) New technologies for the assessment of neuropathies. Nat Rev Neurol 13:203–216. https://doi.org/10.1038/nrneurol.2017.31
留言 (0)